Compare Duke Energy Corp (DUK) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Duke Energy Corp vs Zimmer Biomet Holdings Inc — how do they compare? Duke Energy Corp trades at $116.65 (market cap $91.10B), while Zimmer Biomet Holdings Inc trades at $89.91 (market cap $16.95B). The key difference: Duke Energy Corp is far larger — about 5.4× Zimmer Biomet Holdings Inc's market cap, and Duke Energy Corp pays the higher dividend (3.71%). Which is the better fit depends on your goals — on Pluang, investors hold Duke Energy Corp for 74 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| DUK | ZBH | |
|---|---|---|
Market Cap | $91.10B | $16.95B |
Volume | 4,199,050 | 2,505,240 |
Sector | Utilities | Health |
52-Week High | $133.46 | $103.98 |
52-Week Low | $113.23 | $79.58 |
Typical Hold Time | 74 Days | 89 Days |
Enterprise Value | $183.61B | $24.02B |
Dividend Yield | 3.71% | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Duke Energy (DUK) trades at $116.65, up 1.0% today, with a bullish technical signal and consistent earnings beats. The stock shows strong fundamentals with a 15.78% net income margin and a dividend yield supported by recent $1.09 payouts. Revenue growth is steady, reaching $32.24B in 2025, while analyst consensus targets $134.44, implying upside potential.
The outlook is positive due to earnings momentum and data center demand, but risks include rising Treasury yields pressuring utility stocks and high debt levels. Investors should weigh the reliable dividend against interest rate sensitivity and capital expenditure needs for growth initiatives.
Zimmer Biomet (ZBH) trades at $89.14, up 0.73% today, with a bearish technical signal but strong recent earnings beats. The stock shows robust fundamentals with a 69.87% gross margin and 2025 revenue of $8.23B, though net income margin has declined from 2023 peaks. Analyst consensus is a Buy with a $103.11 target, indicating potential upside, supported by a steady dividend and institutional accumulation.
The outlook is mixed: valuation metrics like a P/E of 21.57 appear reasonable, and earnings momentum is positive, but technical weakness and rising debt-to-asset ratios pose risks. Investment appeal hinges on execution of commercial transformations and procedure volume recovery, balancing growth prospects against competitive and operational headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Duke Energy Corp
Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure
Read more on DUK →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
